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Summary 
 
The human NDR family kinases control diverse aspects of cell growth, and are regulated through 
phosphorylation and association with scaffolds such as MOB1. Here, we report the crystal structure 
of the human NDR1 kinase domain in its non-phosphorylated state, revealing a fully resolved 
atypically long activation segment that blocks substrate binding and stabilizes a non-productive 
position of helix aC. Consistent with an auto-inhibitory function, mutations within the activation 
segment of NDR1 dramatically enhance in vitro kinase activity. Interestingly, NDR1 catalytic 
activity is further potentiated by MOB1 binding, suggesting that regulation through modulation of 
the activation segment and by MOB1 binding are mechanistically distinct. Lastly, deleting the auto-
inhibitory activation segment of NDR1 causes a marked increase in the association with upstream 
Hippo pathway components and the Furry scaffold. These findings provide a point of departure for 
future efforts to explore the cellular functions and the mechanism of NDR1.  
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Introduction 
 
The NDR (Nuclear Dbf-2 Related) kinases, a sub-group of the AGC (cyclic AMP and cyclic GMP 
dependent protein kinases and protein kinase C related protein kinases) family, are conserved across 
eukaryotes (Hergovich et al., 2006; Pearce et al., 2010). Budding yeast (S. cerevisiae) expresses 
three NDR members: Dbf2 and its 77% identical paralog Dbf20 control exit from mitosis, while the 
more divergent Cbk1 promotes cytokinesis and regulates morphogenesis (Bardin and Amon, 2001; 
Rock et al., 2013). Drosophila melanogaster’s two NDR members have divergent functions: 
Tricornered regulates the integrity of epidermal outgrowth and dendritic tiling and branching, while 
Warts is a central player of the conserved Hippo pathway in which it directly phosphorylates the 
transcription coactivator Yorkie to regulate tissue homeostasis (Emoto et al., 2006; Huang et al., 
2005). These divergent functions are maintained in humans: the Warts orthologs LATS1 and 2 are 
primarily studied in the context of the Hippo pathway (Hao et al., 2008; Lei et al., 2008; Zhao et al., 
2010; Zhao et al., 2007), while the Tricornered-related NDR1 and NDR2 kinases (gene names 
STK38 and STK38L) have been ascribed a variety of functions, notably in the regulation of the G1/S 
phase transition (Cornils et al., 2011), T cell migration (Cornils et al., 2010; Tang et al., 2015) and 
centrosome duplication (Hergovich et al., 2009). Despite these apparently divergent roles, more 
recent studies have also outlined potentially overlapping functions between LATS and NDR family 
members, as human NDR1 and NDR2 were shown to phosphorylate the Yorkie ortholog YAP1 
both in vitro and in vivo, allowing them to function as tumor suppressors in the intestinal epithelium 
(Tang et al., 2015; Zhang et al., 2015). 
 
The NDR family kinases possess a conserved and characteristic domain architecture consisting 
minimally of an N-terminal MOB1 co-activator Binding Domain (MBD), a central protein kinase 
domain with an atypically long activation segment (ranging from 63 residues in NDR1/2 to 75 
residues in LATS1/2), followed by a C-terminal Hydrophobic Motif (HM; Figure 1A). Regulation 
of NDR family catalytic function is mediated minimally at three key core levels: firstly by binding 
of MOB1 to the MBD (Hergovich et al., 2006), secondly by auto-phosphorylation on sites within 
the atypically long activation segment in the kinase domain (Ser281/282 in NDR1/2; Ser909/872 in 
LATS1/2; Chan et al., 2005; Stegert et al., 2004; Tamaskovic et al., 2003), and thirdly by 
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phosphorylation of sites within the HM (Thr444/442 in NDR1/2; Thr1079/1041 in LATS1/2) by the 
upstream protein kinases MST1, MST2 and/or MST3 (Chan et al., 2005; Stegert et al., 2005; 
Stegert et al., 2004; Tamaskovic et al., 2003).  In addition to these three core regulatory 
mechanisms, NDR family kinase activity is impacted by scaffold-like proteins including Tao3p in S. 
cerevisiae, which cooperates with the NDR ortholog Cbk1p to control cell polarity (Bogomolnaya 
et al., 2006; Nelson et al., 2003). Tao3p orthologs are also implicated in NDR function: Furry in 
Drosophila melanogaster collaborates with Trc in dendritic branching and planar cell polarity 
(Emoto et al., 2004; Fang and Adler, 2010; Fang et al., 2010; He et al., 2005), and Furry and Furry-
like (FRY and FRYL) in mammals participates with NDR1/2 in mitotic spindle and chromosome 
alignment (Chiba et al., 2009). How precisely the association of FRY/FRYL proteins with the 
mammalian NDR1/2 kinases is mediated and regulated remains an open question. 
 
X-ray crystallographic analysis of yeast Cbk1 bound to Mob2 (Gogl et al., 2015) provided a first 
view of the underlying structure of an NDR family kinase and its binding mode to a MOB protein 
(Supplementary Figure 1A). This study also uncovered a non-canonical mechanism by which a 
phosphorylated HM engages the N-lobe of an AGC family kinase domain to regulate catalytic 
function (Gogl et al., 2015). The MBD of Cbk1 consists of an a-helix (denoted aMOB) followed 
by an extended strand element (denoted N-linker) that together compose the primary docking site 
for the MOB protein. Recent crystal structures of the isolated MBD of human LATS1 and NDR2 
bound to human MOB1 confirmed the general architecture of the MBD and its binding mode to 
MOB proteins (Kim et al., 2016; Kulaberoglu et al., 2017; Ni et al., 2015).  
 
Interestingly, the kinase domain of Cbk1 establishes few direct contacts with its Mob2 activator.  
Instead, these two elements communicate indirectly through bridging interactions involving the C-
terminal HM of Cbk1, which is nestled in a cleft between one surface of the MBD and the N-lobe of 
the kinase domain. Notably, the mode of interaction between the HM and the N-lobe of the kinase 
domain differs substantially from the canonical mode of interaction displayed by other AGC family 
members (Knighton et al., 1991; Xu et al., 2004; Yang et al., 2002). 
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The Cbk1-Mob2 complex structure, together with molecular dynamics simulations, supported a 
model in which Mob2 binding to the MBD induces conformational changes in the MBD that are 
communicated to the kinase domain in part by the HM. The structures of the complex between 
Mob2 and either the unphosphorylated Cbk1 or Cbk1 harboring a phosphomimetic mutation in the 
HM showed no major structural differences. Both co-crystal structures revealed a partially 
disordered activation segment and unresolved helix aC in the kinase domain of Cbk1, suggesting 
that neither the binding of Mob2 nor phosphomimetics were sufficient to force a fully active 
conformation on the Cbk1 kinase domain. While the functional significance of these features was 
not probed in detail, the former hinted at the possibility that the activation segment would play an 
auto-inhibitory role on kinase catalytic function (Bichsel et al., 2004). 
 
Here, we report the crystal structure of the human NDR1 kinase domain at 2.2 Å resolution, 
revealing a completely resolved helix aC and entirely defined, elongated activation segment. The 
activation segment adopts a circuitous path that blocks potential substrate-binding surfaces in the 
immediate vicinity of the kinase active site and around helix aG, while additionally restricting helix 
aC to a non-productive conformation not visualized previously in other NDR family structures. We 
probed the involvement of the MBD and the elongated activation segment for their effects on 
regulating NDR1 protein kinase activity and dynamics by hydrogen-deuterium exchange analysis. 
Our findings support a model in which the elongated activation segment operates independently of 
MOB1 binding to the MBD, which is consistent with their remote sites of action in the protein 
kinase domain structure.  Furthermore, deletion of the auto-inhibitory region within the activation 
segment induced NDR1 association with multiple activating proteins in cells, and several of these 
interactions were further enhanced by serine/threonine phosphatase inhibition with okadaic acid. 
These findings reveal an unanticipated regulatory role for the activation segment of NDR1 in 
modulating not only the intrinsic catalytic function of the kinase domain but also the interactions 
with the Furry scaffold FRYL and upstream activating kinases, which may afford multiple 
opportunities to modulate NDR1/2 activity in the context of living cells. 
 
Results 
Structure of the NDR1 protein kinase domain 
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To visualize the regulatory states that could shed light onto NDR1 kinase signaling, we set out to 
determine the structure of the isolated kinase domain of NDR1. To delimit a fragment of NDR1 
suitable for crystallization, we first performed limited proteolysis on an NDR1 fragment (residues 
12–418 encompassing the MBD and the kinase domain, denoted NDR1MBD-KD) that could be 
expressed and purified from bacteria (Figure 1A). While the MBD of this NDR1 construct was 
readily cleaved from the kinase domain, the atypically long activation segment of NDR1 was 
surprisingly resistant to proteolysis despite the presence of numerous predicted protease sites 
(Supplementary Figure 2A). We next expressed and purified the isolated kinase domain of human 
NDR1 (residues 82–418, denoted NDR1KD; Figure 1A) from E. coli. Intact mass analysis did not 
reveal significant autophosphorylation (Supplementary Figure 2B). Analytical ultracentrifugation 
demonstrated that NDR1KD was a monomer in solution under all conditions tested (Supplementary 
Figure 2C). We crystallized NDR1KD in the presence of the ATP analog b, g-imidoadenosine-5’-
triphosphate (AMP-PNP), obtaining well-diffracting crystals that enabled us to determine the 
crystal structure by molecular replacement (Rfactor/Rfree = 18.0%/21.4%, 2.2 Å, see Materials and 
Methods and Table 1 for details). The crystal asymmetric unit contained two NDR1KD molecules, 
each bound to AMP-PNP, with all but the most N-terminal and C-terminal residues ordered, 
including the entire length of the 63-residue activation segment (Supplementary Figure 3A). As the 
two chains were virtually identical (main-chain alpha-carbon RMSD=0.051 Å over 337 ordered 
residues), we focused our descriptions to a single chain A (Figure 1B, see Figure 2 for a structure-
based sequence alignment of the catalytic domain of the NDR1/2 kinases). 
 
Structure of the NDR1 kinase domain reveals an inactive conformation   
NDR1KD adopts the bilobal fold typical of protein kinases (Figure 1B). The most notable and 
distinguishing features of the structure included a fully ordered, atypically long activation segment 
that occupies established substrate binding sites in other protein kinases (see below), and a non-
productively oriented helix aC within the kinase N-lobe suggestive of an inactive state (see below).  
 
Commencing at the DFG motif, the elongated activation segment (residues 230–292, Figure 1B) 
emerged from the catalytic cleft and wrapped around the front face of the C-lobe, circumnavigating 
helix aG, before re-directing toward the catalytic cleft and terminating in the APE motif. The 
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elongated activation segment adopted an irregular extended conformation interspersed by three 
helical regions, giving rise to an alternation of extended and helical segments: EX1 (230–238), H1 
(239–246), EX2 (247–256), H2 (257–261), EX3 (262–263), a kinked helix denoted H3 (264–280), 
and EX4 (281–293). The extensive interface between the activation segment and the kinase domain, 
covering 2740 Å2, was mediated by a mixture of hydrogen bonds, salt bridges and hydrophobic 
interactions (Supplementary Figure 4). We note that only a small portion of the activation segment 
centered on helix H1 was involved in crystal packing interactions (contact surface = 694 Å2) 
(Supplementary Figure 3B&C). 
 
Comparison of NDR1 with a typical active-state protein kinase structure, such as that of 
Phosphorylase Kinase (PHK; PDB 2PHK), revealed an outwardly rotated position of helix aC 
(Figure 3A).  As a result of this non-productive orientation, the conserved Glu137 side chain within 
helix aC was swung away from the catalytic cleft (≈100° relative to the corresponding residue E91 
in active PHK) towards the solvent. This precluded formation of an essential salt bridge with 
Lys118 (within b3) that would enable Lys118 to productively coordinate the a- and b-phosphates 
of ATP for catalysis (Figure 3A top inset). The non-productive conformation of helix aC was 
stabilized in part by contacts with the extended region EX1 of the activation segment, and involved 
a salt bridge between the Mg2+-coordinating residue Asp230 of the DFG motif and Arg138 of helix 
aC. The inactive state of the kinase domain was further evidenced by a broken regulatory (R-) spine 
(Figure 3B) and the absence of Mg2+ (despite its presence in the crystallization buffer), both of 
which are critical for proper ATP coordination and catalysis (Figure 3; Endicott et al., 2012). 
 
Structural comparison of NDR1 with other protein kinases bound to either a peptide substrate 
(Figure 3A) or intact substrates (Supplementary Figure 5) suggested that the elongated activation 
segment of NDR1 may block substrate binding at two levels: first at the primary phospho-acceptor 
binding site in the catalytic cleft (Figure 3A, bottom inset), and second at higher-order substrate 
binding sites involving helix aG (Supplementary Figure 5). The former is apparent by overlap of 
activation segment elements EX1 and EX4 of NDR1 with the Modified Cantley (MC) peptide 
substrate bound to PHK (Figure 3A bottom inset), while the latter is apparent by overlap of the 
activation segment elements H3, EX2, and EX1/H1 with the respective substrate components in the 
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PKR-eIF2a (Dey et al., 2005), the ROCK1-RhoE (Komander et al., 2008) and the BRAF-MEK1 
(Haling et al., 2014) enzyme-substrate complexes (Supplementary Figure 5).  
 
The activation segment of NDR1 serves an auto-inhibitory role  
Based on our crystallographic findings, we hypothesized that the structure of the NDR1 kinase 
domain reflected a down-regulated state that was maintained in part by the inhibitory conformation 
of the elongated activation segment. To test this notion, we sought to introduce point mutations and 
deletions into NDR1, aimed at disrupting the activation segment from its contact surface on the 
kinase domain (see Supplementary Figure 6A-C for schematic). We chose to introduce mutations 
into the longer NDR1MBD-KD construct because unlike NDR1KD, it preserved many of the key 
regulatory properties of the full-length enzyme (Figure 4).  As assessed by auto-phosphorylation 
and by phosphorylation of the previously reported substrate RAB3A-interacting protein (gene 
RAB3IP; aka Rabin8; Chiba et al., 2013; Ultanir et al., 2012), wild-type NDR1MBD-KD displayed 
repressed catalytic activity (Figure 4A-C) that could be potently relieved by addition of MOB1 (at 
the level of kinase autophosphorylation and RAB3IP phosphorylation) and to a lesser extent by 
phospho-HM (at the level of RAB3IP phosphorylation). In contrast, NDR1KD displayed higher basal 
catalytic activity that was not responsive to the addition of MBD or phospho-HM (Figure 4B&C). 
These results were consistent with a model in which the MBD of NDR1 exerts an additional 
repressive effect on the adjacent kinase domain that can be relieved by the binding of NDR1 to 
MOB1 and to the HM peptide. 
 
We next tested the effect of activation segment mutations on the kinase activity of NDR1MBD-KD. 
Individual mutations in NDR1MBD-KD of residues K267 (aliphatic portion of the side chain engaging 
a hydrophobic pocket formed by Y319, Y313, T342, P321, P320 and P321), W271 (binding a 
hydrophobic pocket formed by P215, L278, Y288, I311 and P320), K272 (binding to D181 and 
G319 backbone via hydrogen bonds), and Y331 (binding a hydrophobic pocket formed by Y246, 
H251, P291, F294, V334 and M335)  (Supplementary Figure 6D, E, F, & H, respectively) 
stimulated RAB3IP phosphorylation by up to 10-fold (Figure 5A; Supplementary Figure 7). The 
WY271/331CA double mutation increased RAB3IP phosphorylation by 50-fold.  
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A previously reported five-site activating mutation within the activation segment of NDR1 (Bichsel 
et al., 2004), denoted 5A (K265A/R266A/K267A/K272A/R273A), resulted in a 50-fold increase in 
NDR1 phosphorylation of RAB3IP (Figure 5A; see Supplementary Figure 7 for quantification). The 
mechanism by which these mutations act was not previously discerned, but only residues K267 and 
K272 made appreciable contacts with the surface of the kinase domain in our crystal structure 
(Supplementary Figure 6D, F & G). We hypothesized that mutations at these two sites were the 
primary drivers of activation by causing dissociation of the inhibitory activation segment from its 
contact surface on the kinase domain. In partial support of this inference, the K267A and K272A 
mutations on their own, unlike the other single site lysine mutations, displayed some ability to 
stimulate kinase activity (Figure 5A). However, robust activation was only observed when all five 
sites were mutated, suggesting that all five sites collaborate to relieve auto-inhibition.  
 
The activation segment of NDR1 houses 10 serine/threonine sites with potential for phospho-
regulation (Supplementary Figure 8A). Ser281 was identified previously as an auto-phosphorylation 
site that when mutated to alanine compromised full-length enzyme function in vitro and in cells 
(Tamaskovic et al., 2003). We confirmed this finding using the NDR1KD crystallization construct 
(Supplementary Figure 8B) and further showed that mutation of Ser281 to Glu restored catalytic 
function, but not as potently as a Y331A mutation, which disrupts a key contact of the activation 
segment insert with the kinase domain C-lobe (Supplementary Figure 8C).  In the crystal structure 
of NDR1, Ser281 resides in a solvent-accessible position following helix H3. We reason that auto-
phosphorylation on Ser281 may only weakly perturb the auto-inhibitory conformation of the 
activation segment, and that any essential phospho-regulatory function derives from its ability to 
stabilize a productive conformation of the activation segment through canonical phosphate 
coordinating interactions with arginine 211 of the HRD motif and with histidine 133 of helix aC.  
 
We further corroborated the auto-inhibitory function of the elongated activation segment by 
deletion analysis. We replaced stretches of 34, 38 and 40 residues in the elongated activation 
segment with a single glycine residue while maintaining the DFG motif, the APE motif and the Ser 
281 autophosphorylation regulatory site (Supplementary Figure 6C). Compared to the wild-type 
NDR1MBD-KD, the D34G, D38G, and D40G deletion mutants displayed ~200-fold, 500-fold and 70-
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fold increases in RAB3IP phosphorylation, respectively (Figure 5B). For all mutants, including 
those displaying strongest activation, kinase activity could be further potentiated by the addition of 
MOB1 (Figure 5, see Supplementary Figure 7 for quantification).  This observation indicated that 
the regulation of NDR1 kinase activity by the activation segment and by MOB1 represent 
independent layers of control.  
 
Similar activating effects brought by MOB1 binding and activating mutations were also observed 
when GST-YAP50-171 (YAP fragment encompassing amino acids 50 to 171) was used as an NDR1 
substrate in vitro (Supplementary Figure 9). Taken together, our data demonstrated that the 
conformation of the activation segment visualized in the NDR1KD crystal structure serves an auto-
inhibitory role.  
 
 
Hydrogen-deuterium exchange corroborates independent regulation of NDR1 by the atypical, 
elongated activation segment and MOB1A binding 
Comparison of the NDR1KD structure presented here and the Cbk1-Mob2 co-crystal structure 
reported previously revealed that the activation segment of NDR kinase engages the kinase domain 
remotely from the MOB-MBD site of contact (Figure 6, Supplementary Figure 1C). The only point 
of convergence between the two could be helix 𝛼C, which is disordered in the Cbk1-Mob2 crystal 
structure. This, together with our enzymatic characterizations, provided support to the notion that 
the activation segment and MBD regulatory inputs might operate independently to regulate protein 
kinase activity. To investigate the impact of two regulatory inputs on the structure and dynamics of 
NDR1 free from the constraints of a crystal lattice, we employed hydrogen-deuterium exchange 
coupled mass spectrometry (HDX-MS). This method measures the rate of deuterium incorporation 
into a target protein upon the substitution of H2O by D2O. For this experiment, we chose to analyze 
the NDR1MBD-KD 5A mutant over the most potent Δ38G deletion mutant because it more closely 
preserved protein sequence and length in the activation segment for a more useful comparison to 
WT NDR1MBD-KD with or without MOB1A binding (we did not use full length NDR1, because the 
construct could not be expressed in E. coli). Consistent with our structural and enzymatic 
inferences, the 5A mutations and the addition of MOB1A affected HDX in distinct regions of the 
kinase construct (Figure 6, graph numbers I-VIII), leaving other regions, with varying degrees of 
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solvent accessibility, relatively unaffected (Figure 6, graph numbers VIIII-XI). MOB1A binding 
mostly affected the N-terminus of the kinase construct, including the MBD, the MBD-kinase 
domain linker and the area around the catalytic base (HRD peptide). MOB1A addition substantially 
reduced the rate of deuterium incorporation in the MBD and the MBD-kinase linker (Figure 6, 
graph numbers I, II, and III), consistent with the fact that complex formation would directly mask 
these regions from exchange. In contrast, MOB1A addition increased deuterium incorporation in 
the catalytic site in both NDR1 WT and 5A constructs (Figure 6, graph number IV).  Conversely, 
the activating 5A mutation did not change the rate of deuterium incorporation in the kinase N-
terminus and only modestly increased D2O incorporation at the catalytic site (Figure 6, graph 
numbers I, II, III, and IV).  
 
In contrast, the 5A mutation strongly affected peptides within the activation segment insert, the 
region around helix aG, and the activation segment region containing the APE motif, which led to 
increased HDX in these regions (Figure 6, graph numbers VI, VII, and VIII). HDX in these areas 
was only marginally affected by MOB1A binding. Lastly, only in the area around the DFG motif 
did we observe increased HDX for both the 5A mutation and MOB1A addition (Figure 6, graph 
number V).  This peptide is notable in being centrally located between the sites of interaction in the 
MOB-MBD complex and the activation segment in the kinase domain core. Neither MOB1A 
binding nor 5A mutation stabilized helix aC in our HDX experiments, which might explain the 
disordered helix aC in the previous yeast Cbk1-Mob2 co-crystal structure (Supplementary Figure 
1A, Figure 6, graph number VIIII). Overall, our HDX results are consistent with independent modes 
of action for kinase regulation by MOB1 engagement and by the activation segment. 
 
Effect of activating mutations and MOB1 binding on enzyme kinetics  
We next examined how mutation of the elongated activation segment and binding to MOB1 
affected the enzymatic parameters of NDR1MBD-KD phosphorylation of RAB3IP in vitro. A change 
in Km for substrate would reflect modulation of enzyme-substrate engagement, while a change in 
kcat would reflect modulation of enzyme catalytic efficiency. Several kinases, such as PKR, ROCK, 
and RAF utilize helix aG to interact with their substrates (Dey et al., 2005; Haling et al., 2014; 
Supplementary Figure 6; Komander et al., 2008). Since the elongated activation segment of NDR1 
hinders access to helix aG, we predicted that activation segment mutants might cause a pronounced 
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improvement in Km, if NDR1 also used helix aG to engage the substrate RAB3IP. Conversely, we 
predicted that MOB1 binding to NDR1 would cause a pronounced improvement on kcat, since the 
site of MOB1 binding to NDR1 is remote from the substrate recognition infrastructure in the kinase 
C-lobe. In comparing the enzyme kinetic parameters of the NDR1MBD-KD Y331A and 5A mutants to 
the wild-type (as above, we chose these mutants over the most potent Δ38G deletion mutant 
because they more closely preserved protein sequence and length in the elongated activation 
segment for more meaningful comparison to the wild-type NDR1), we observed that the kcat for the 
phosphorylation of RAB3IP was substantially improved by 40 and 200-fold respectively, while Km 
was not enhanced comparably (Figure 7). We also observed a further enhancement of kcat for the 
phosphorylation of RAB3IP by all three NDR1 constructs upon MOB1A binding. These results 
indicated that the activation segment of NDR1 and MOB1 both affect NDR1 kinase activity 
primarily by modulating the catalytic efficiency of the enzyme and not by modulating substrate 
engagement at least in the case of the RAB3IP substrate. Our kinetic results raise the possibility that 
the phospho-acceptor region of RAB3IP may bind to the NDR1 active site in a way that differs to 
some degree from canonical kinase-substrate complexes and therefore may not be significantly 
impeded by the NDR1 activation segment as one may expect based on our structural findings. 
 
Effect of activating mutations on NDR1 function in cells  
The murine NDR1 homolog Ndr2 was shown to phosphorylate YAP1 and influence Hippo pathway 
signaling in the intestinal epithelium (Zhang et al., 2015).  We tried to exploit this finding to test 
NDR1 structure-function relationships in cells using a TEAD-luciferase reporter assay in SW480 
colorectal cancer cells. However, although we observed reporter repression by NDR1, as has been 
seen for Ndr2, the effect of wild-type NDR1 was subtle (Figure 8A), and mutations expected to 
cause activation or impairment of NDR1 catalytic activity also had minimal effects (Figure 8A).  
 
As an alternative means to assess structure-function relationships in cells, we therefore took a 
systems-wide approach using interaction proteomics to analyze the consequences of the most potent 
Δ38G deletion mutation on the interactions established by NDR1.  We generated stable cell lines 
inducibly expressing BirA*-FLAG-tagged versions of NDR1 wild-type and Δ38G (the 5A mutant 
was expressed to markedly lower levels and thus could not be used in this study). A set of cells was 
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treated with okadaic acid (OA) to inhibit PP2A-family phosphatases, a treatment that led to multiple 
changes in protein-protein interaction within the Hippo signaling pathway in our previous study 
(Couzens et al., 2013). FLAG affinity purification was performed in biological duplicates for each 
condition, and results analyzed alongside negative controls by mass spectrometry (see STAR 
methods for details). Spectral counts were further evaluated with the statistical tool SAINTexpress 
(Teo et al., 2014) to identify high-confidence interaction partners, and the resulting data were 
visualized with ProHits-viz (Knight et al., 2017).  
 
Wild-type NDR1 purifications readily recovered MOB1A, and the Δ38G activation loop deletion 
did not abrogate this interaction, although okadaic acid treatment appeared to potentiate it (Figure 
6A). A similar pattern was observed for MOB2, a paralog of MOB1 that can associate with NDR1 
and NDR2, but not with LATS1 or LATS2 (Bichsel et al., 2004; Hergovich et al., 2005; Xiong et 
al., 2017). Interestingly, while the Δ38G mutant did not lose any interactors relative to the wild-type 
protein, it did yield many additional interactors upon treatment with okadaic acid. Amongst these 
were the upstream activator kinases STK3 and STK4 (also known as MST2 and MST1, 
respectively) and their partners in Hippo pathway signaling, SAV1 and RASSF2 (interactors 
previously linked to NDR kinases are shown in Figure 8B; all interactions are reported in Supp. 
Table 1). These observations provided evidence that in the context of living cells, the extended 
activation segment of NDR1 may play an important regulatory role for the recruitment of kinase 
activators. Since MOB1A recruits these components in a phospho-dependent manner through direct 
interaction with an autophosphorylation site in STK3 and STK4 (Couzens et al., 2013; Couzens et 
al., 2017; Ni et al., 2015; Rock et al., 2013; Xiong et al., 2017), we were not surprised to see an 
okadaic acid-mediated induction. However, the absence of interaction in the context of the wild-
type protein suggests an inhibitory role of the activation segment in enabling these associations. 
 
Besides the Hippo pathway components, another protein selectively recruited to the Δ38G mutant 
was the less well characterized activator Furry (FRYL), whose orthologs work as critical scaffolds 
for NDR kinases (Bogomolnaya et al., 2006; Chiba et al., 2009; Emoto et al., 2004; Fang and Adler, 
2010; Fang et al., 2010; He et al., 2005; Nelson et al., 2003). FRYL association with NDR1 was 
	 14	
further enhanced by phosphatase inhibition (Figure 8B&C). This provides evidence suggesting that 
the interaction between FRYL and NDR is a regulated event.  
 
To validate our interaction proteomics observations for FRYL, cells expressing the BirA*-FLAG 
tagged wild-type and Δ38G constructs as above were treated with okadaic acid or DMSO and used 
in an immunoprecipitation/immunoblotting experiment to detect the recovery of FRYL with an 
antibody to the endogenous protein. FRYL was recovered in the precipitates of wild-type NDR1 but 
not in the negative control, and this interaction was far more pronounced for the Δ38G protein 
(Figure 8C). Furthermore, inhibition of phosphatases by okadaic acid potentiated this interaction 
(Figure 8C). These findings validate our proteomics observations that the atypically long activation 
segment of NDR1 regulates its association with the known activator FRYL. 
 
Discussion  
NDR family kinases are regulated by distinct mechanisms, notably binding of the MOB proteins, 
auto-phosphorylation within its atypically long activation segment, transphosphorylation on the 
hydrophobic motif by upstream kinases, and association with scaffolding proteins (SAV1, RASSF2, 
Furry family). Yet, the relative contribution of these different regulatory steps towards kinase 
activation and signaling, as well as the potential for synergy, had not been fully elucidated. 
 
Here, we described the high-resolution structure of an inactive NDR1 kinase domain, revealing a 
completely resolved and atypically long activation segment and fully ordered helix aC. Both in 
vitro kinase assays and HDX-MS experiments demonstrate that regulation of NDR1 kinase by 
MOB1 binding and by modulation of the elongated activation segment occur through independent 
mechanisms. Our in vitro kinase analyses also showed that disrupting the interaction of the 
elongated activation segment with the surrounding kinase domain dramatically increased NDR1 
phosphorylation of RAB3IP primarily at the level of kcat and not Km. Whether other substrates of 
NDR1, which may use altogether different modes of engagement to the NDR1 kinase domain, 
would be similarly affected remains to be determined.  
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In addition to increasing the intrinsic kinase activity of NDR1, disruption of the atypically long 
activation segment drastically increased association of NDR1 with the upstream kinases STK3 and 
STK4, which target the NDR1 hydrophobic motif for phosphorylation, and with the Furry family 
scaffold, FRYL. This finding suggested that the activation segment of NDR1 may control NDR1 
interaction with physiological regulators, although the basis for this effect, including how the auto-
inhibitory conformation of the activation segment is relieved, remains to be determined. However, 
the finding that the binding of NDR1 to STK3, STK4 and FRYL was further stimulated by the 
inhibition of phosphatases with okadaic acid suggests that phosphorylation plays an integral role in 
the recruitment of these factors. For STK3 and STK4, we hypothesize that recruitment occurs 
through their direct interaction partner MOB1, which binds to the autophosphorylated forms of both 
protein kinases (Couzens et al., 2013; Couzens et al., 2017; Ni et al., 2015; Rock et al., 2013; Xiong 
et al., 2017). Why okadaic acid is not able to stimulate STK3 and STK4 binding to wild type NDR1 
remains an open question. 
 
The NDR family kinase Warts was first identified in Drosophila as a tumor suppressor and 
subsequently found conserved in mammals with the two human orthologues (LATS1 and LATS2) 
playing a key role in regulating the Hippo tumor suppressor pathway. Despite the fast pace in which 
the Hippo pathway components have been identified and characterized for function, few studies 
have focused on the mechanistic details of how the catalytic output of LATS1/2 is regulated. Given 
the similarity between all NDR family kinases, our detailed studies on NDR1 may provide a useful 
model for understanding the general principles that govern the regulation of other NDR family 
members such as LATS1/2. 
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Main Figure and Table Legends: 
 
Figure 1. Crystal structure of the protein kinase domain of human NDR1 in its non-
phosphorylated state. A. Domain architecture of NDR1 kinase highlighting an atypically long 
activation segment and two phosphoregulatory sites, S281 and T444. Constructs used in this study 
are highlighted above with black lines. B. Ribbon representation of the kinase domain of human 
NDR1. 
 
Figure 2. Structure-based sequence alignment of the kinase domain of NDR1. Secondary 
structure elements are highlighted above the sequence. Degree of conservation highlighted by black 
(most) to white (least) shading. Species from top to bottom correspond to human (NP_009202.1, 
NP_055815.1), gorilla (NP_001075071.1), bovine (NP_001075071.1), eagle (XP_010582907.1), 
zebrafish (NP_998621.1), lizard (XP_003220400.1), turtle ( XP_007063535.1), fly (NP_524170.2), 
worm (NP_508627.5), and budding yeast (NP_014238.3). Red star indicates the previously 
identified auto-phosphorylation site, Ser281. Blue stars indicate conserved basic residues implicated 
in the canonical stabilization of the phosphorylated activation segment in a productive 
conformation. Orange circles indicate serine and threonine residues in the activation segment which 
may possess phospho-regulation potential. The alignment was generated using CCP4 ALINE (Bond 
and Schuttelkopf, 2009). 
 
Figure 3. Inactive state features of the kinase domain of NDR1. A. Superimposition of NDR1KD 
in green and the kinase domain of Phosphorylase Kinase (PHKKD) in grey bound to the MC peptide 
substrate in cyan (PDB: 1PHK; Lowe et al., 1997). Top right inset highlights the non-productive 
outward rotated (≈100°, as indicated by the red arrow) position of helix aC in NDR1KD. Bottom 
right inset highlights steric clash of the atypically long activation segment of NDR1KD with the MC 
peptide substrate bound to PHKKD. B. Hydrophobic catalytic and regulatory spine representation of 
NDR1KD. 
 
Figure 4. Activation of NDR1 kinase by MOB1 and/or a phosphorylated hydrophobic motif 
peptide. A. In vitro kinase assay analysis of wild-type GST-NDR1MBD-KD in the presence and 
absence of MOB1 activator and/or a phospho-HM peptide in trans. The top two panels show the 
autoradiograph, and the bottom three panels show protein loading by Coomassie staining. B. In 
vitro auto-phosphorylation analysis of NDR1MBD-KD versus NDR1KD in the presence and absence of 
MOB1 and/or a phospho-HM peptide in trans. The top panel displays the autoradiograph, and the 
bottom two panels show protein loading by Coomassie staining. C. In vitro auto-phosphorylation 
and phosphorylation of RAB3IP substrate by NDR1MBD-KD and NDR1KD, in the presence and 
absence of MOB1 and/or a phospho-HM peptide in trans. The top two panels display 
autoradiographs for NDR1 auto-phosphorylation and RAB3IP phosphorylation, respectively. The 
bottom three panels show protein loading by Coomassie staining.  
 
Figure 5. Mutational analysis of the atypically long activation segment of human NDR1. (See 
also accompanying Supplementary Figure 6 for schematic of mutations tested) A. In vitro 
phosphorylation of RAB3IP by wild-type NDR1MBD-KD and the indicated point mutants without (left 
	 22	
panel) and with (right panel) the addition of MOB1A. Loading controls are shown by Coomassie 
staining. B. In vitro phosphorylation of the NDR1 substrate RAB3IP by NDR1MBD-KD wild-type and 
the indicated activation segment deletion mutants without (left panel) and with (right panel) the 
addition of MOB1A; loading controls are shown by Coomassie staining. Quantification of the 
autoradiography signals is shown at the bottom (n=3 independent experiments; error bars, SEM). 
 
Figure 6. Conformational and dynamics analysis of NDR1 by hydrogen-deuterium exchange 
(HDX) mass spectrometry. HDX-coupled mass spectrometry was used to evaluate the solvent 
accessibility of NDR1MBD-KD upon addition of MOB1A or upon the introduction of the 5A 
activating mutations. Changes to the average deuterium incorporation are highlighted in the 
structural superimposition of NDR1KD and the Cbk1-Mob2 complex, with appended HDX plots for 
the indicated regions. For each plot corresponding to the indicated peptide region, HDX time course 
profiles are shown for NDR1MBD-KD wild-type alone (black), NDR1MBD-KD wild-type with the 
addition of MOB1A (blue), NDR1MBD-KD 5A alone (green), and NDR1MBD-KD 5A with the addition 
of MOB1A (purple). HDX plots for peptide elements labeled I to IV represent regions of NDR1 that 
were most greatly affected by MOB1A binding, as shown by large deviations between blue and 
black profiles and between purple and green profiles (Note: in panel III, the trace for NDR1MBD-
KD+MOB1 in blue overlaps with the trace for NDR1MBD-KD5A+MOB1 in pink). HDX plots VI to 
VIII represent regions of NDR1 most greatly affected by introduction of the 5A mutations as 
evidenced by large deviations between green and black profiles and between purple and blue 
profiles. HDX plots in panel V represent the DFG motif of NDR1 that was greatly affected by both 
the addition of MOB1 and the introduction of the 5A mutations. HDX plots VIIII to XI are controls 
representing regions of NDR1 that were not affected by either MOB1 binding or 5A mutations. 
HDX plots in panels VIIII, X, and XI represent the NDR1 helix αC, a C-terminal region of the 
kinase domain (denoted C-terminal tail peptide 1), and helix αF, respectively. Data points represent 
means of 3 replicates; error bars, SEM. 
 
Figure 7. Michaelis-Menten kinetic analysis of the phosphorylation of the NDR1 substrate 
RAB3IP by NDR1MBD-KD. Phosphorylation kinetic analysis of NDR1MBD-KD WT (top panel), 
Y331A mutant (middle panel), and 5A mutant (bottom panel) in the absence of MOB1 (left 
column) or in the presence of MOB1 (right column). n=3 experiments done in technical duplicate; 
error bars, SEM. 
 
Figure 8. Analysis of NDR1 activating mutations in cells. A. TEAD luciferase reporter analysis 
of NDR1 in Hippo signaling. SW480 cells were co-transfected with the indicated MYC-tagged 
NDR1 constructs or empty vector, a TEAD luciferase reporter and a Renilla luciferase control 
reporter. Luciferase activities were normalised for Renilla luciferase control reporter activities and 
expressed relative to reporter activities in the absence of NDR1 (vector). The Western blot 
illustrates NDR1 expression levels (b-actin was detected in parallel as a loading control). Asterisks 
indicate a band seen in the absence of MYC-NDR1 expression and in non-transfected cells, which 
likely represents endogenous c-MYC. n=10 experiments (9 in technical duplicate, 1 singlet); error 
bars, SEM. Note that transiently expressed MYC-NDR1 Δ38G was consistently expressed at lower 
levels than other NDR1 constructs. B. Affinity purification coupled mass spectrometry analysis of 
NDR1 interactions in cells. Cells stably expressing BirA*-FLAG-tagged wild-type NDR1 or NDR1 
harboring a Δ38G deletion were induced with tetracycline (total 24 hours) and treated with 150 nM 
okadaic acid (OA) or DMSO for the last 2.5 hours of induction. Affinity purification coupled to 
mass spectrometry was performed in biological duplicates alongside negative controls, and high-
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confidence interactions were scored with SAINTexpress and visualized with ProHits-viz (see 
legend inset). Only interactions with previously reported or suspected regulators are depicted here; 
the complete list of high-confidence interactions is given in Supplementary Table 1. C. Validation 
of the increased interactions between NDR1 Δ38G and FRYL by immunoprecipitation and 
immunoblotting. FLAG immunoprecipitates or total lysates were incubated with antibodies to 
FLAG or endogenous FRYL; the negative control consisted of the parental cell line. 
 
Table 1. Crystallographic data collection and refinement statistics for human NDR1KD.  
 
 
STAR METHODS: 
 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Sheep anti-mouse IgG coupled to HRP GE Healthcare Cat#NA931; 
RRID:AB_772210 
Donkey anti-rabbit IgG coupled to HRP GE Healthcare Cat#NA934; 
RRID:AB_772206 
Mouse anti-FLAG M2 coupled to HRP Sigma-Aldrich Cat#A8592-.2MG; 
RRID:AB_439702 
Rabbit anti-FRYL antibody Bethyl Cat#A302-643A-M; 
RRID:AB_1058725 
Magnetic anti-FLAG M2 beads slurry Sigma-Aldrich Cat#M8823; 
RRID:AB_2637089 
Mouse anti-MYC 9E10 IgG Thermo Fisher 
Scientific 
Cat#MA1-81358; 
RRID:AB_930029 
Mouse anti-beta-actin IgG (AC-15) Abcam Cat#ab6276; 
RRID:AB_2223210 
 
Goat anti-mouse IgG coupled to DyLight 680 Thermo Fisher 
Scientific 
Cat#35518; 
RRID:AB_614942 
   
Bacterial and Virus Strains  
E. coli BL21 (DE3) CodonPlus-RIL Agilent Cat#230280 
   
Chemicals, Peptides, and Recombinant Proteins 
Okadaic acid LC Labs Cat#O-5857-1mg 
Protease inhibitor cocktail Sigma-Aldrich Cat#P8340  
ECL prime Western blotting detection reagent  GE Healthcare Cat#45002401 
Lipofectamine 2000 transfection reagent Thermo Fisher 
Scientific 
Cat#11668019 
 
32P-g-ATP Perkin Elmer Cat#BLU002Z250U
C 
Adenosine 5′-(β,γ-imido)triphosphate lithium salt hydrate 
(AMP-PNP) 
Sigma-Aldrich Cat#A2647-5MG 
 
Adenosine 5′-triphosphate (ATP) disodium salt hydrate 
(ATP) 
Sigma-Aldrich Cat#A26209-10G 
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Critical Commercial Assays 
Dual-Luciferase® Reporter Assay System Promega Cat#E1910 
   
Deposited Data 
Interaction proteomics dataset Xiong et al., 2018; 
MassIVE 
https://massive.ucsd.
edu/ (MassIVE ID 
MSV00008179 ) 
Interaction proteomics dataset Xiong et al., 2018; 
ProteomeXchange 
http://www.proteome
xchange.org/ 
(ProteomeXchange 
ID PXD008416) 
Protein Data Bank This study PDB ID: 6BXI 
   
Experimental Models: Cell Lines 
HEK293 Flp-In T-REx 
Invitrogen Cat#R780-07, 
RRID:CVCL_U427 
SW480 gift from Chris Lord, 
ICR; originally 
obtained from ATCC 
Cat#CCL-228 
 
   
Oligonucleotides 
hsNDR1(nco,m12)f ccgCTCGAGttatctatttct
tttccaggtttc 
Sigma 
 
hsNDR1(i418,stp,kpn)r 
 
catgCCATGGctatgagt
aacc 
Sigma 
 
hsNDR1(k238a)f cggGGTACCTTAaatat
cagattctg 
Sigma 
 
hsNDR1(k238a)r ctttgcacaggactggcaaa
agcacataggac 
Sigma 
 
hsNDR1(h241a)f 
 
gtcctatgtgcttttgccagtcc
tgtgcaaag 
Sigma 
 
hsNDR1(h241a)r 
 
ggactgaaaaaagcagcta
ggacagaattttatagg 
Sigma 
 
hsNDR1(d256a)f 
 
cctataaaattctgtcctagct
gcttttttcagtcc 
Sigma 
 
hsNDR1(d256a)r 
 
cagcctccccagtgctttcact
ttccag 
Sigma 
 
hsNDR1(w271c)f 
 
ctggaaagtgaaagcactgg
ggaggctg 
Sigma 
 
hsNDR1(w271c)r 
 
ggaaagcagaaacctgtaa
aagaaatagacg 
Sigma 
 
See Supp. Table 2 for the complete primer list   
   
Recombinant DNA 
pDEST-pcDNA5-BirA*-FLAG N-term Couzens et al., 2013 Vector ID: V8164 
(LTRI database) 
pDEST-pcDNA5-BirA*-FLAG N-term-NDR1 and 
derivatives 
this study 
 
N/A 
 
pETM-30 EMBL https://www.embl.de/
pepcore/pepcore_se
rvices/cloning/choice
_vector/ecoli/embl/p
opup_emblvectors/ 
pETM-30-Hs NDR1(82-418) and derivatives this study N/A 
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pETM-30-Hs NDR1(12-418) and derivatives this study N/A 
8xGTIIC-luciferase  obtained from Stefano 
Piccolo via Addgene 
(Dupont et al., 2011) 
Cat#34615 
 
ptkRL Renilla luciferase control plasmid Promega N/A 
pDNR-MCS SA modified from 
Clontech pDNR Dual 
(Colwill et al., 2006) 
N/A 
 
pcDNA5 FRT TO-MYC-NDR1 and derivatives this study N/A 
   
Software and Algorithms 
MS data storage and analysis: ProHits Liu et al., 2010 N/A 
MS data, Significance Analysis of INTeractome analysis: 
SAINT 
Teo et al., 2014 
 
Version exp3.3 
 
MS data visualization: ProHits-viz Knight et al., 2017 N/A 
HDX workbench Scripps Institute 
Florida 
http://hdx.florida.scri
pps.edu/hdx_workbe
nch/Home.html 
Coot Emsley et al., 2004 
 
http://www2.mrc-
lmb.cam.ac.uk/perso
nal/pemsley/coot/ 
Phenix Afonine et al., 2012 http://www.phenix-
online.org/ 
PyMol Schrodinger CCP4 program suite 
Refmac Winn et al., 2003 CCP4 program suite 
 
Prism 7 GraphPad Software, 
Inc. 
http://www.graphpad
.com 
   
Other 
LTQ Orbitrap Elite / Velos  Thermo Fisher 
Scientific 
N/A 
 
Odyssey® Imaging System LI-COR N/A 
Victor X5 Multilabel Plate Reader PerkinElmer N/A 
 
Contact for reagent and resource sharing: 
Further information and requests for reagents may be directed to, and will be fulfilled by the Lead 
Contact Frank Sicheri (sicheri@lunenefeld.ca). 
 
Experimental model and subject details: 
For the TEAD reporter assays, SW480 colorectal adenocarcinoma cells (male) were obtained from 
Chris Lord (ICR, London), who purchased the cells from ATCC (see table above) and confirmed 
cell line identity in the expanded laboratory stock by STR typing (March 2016). The cell stock was 
also confirmed to be free of mycoplasma. The cells were grown at 37°C in DMEM containing 4,500 
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mg/L glucose, supplemented with 10% Fetal Bovine Serum and antibiotics (100 mg/L streptomycin 
sulfate, 60 mg/L benzylpenicillin). 
 
For interaction proteomics, Flp-In T-REx 293 cell lines (female) were obtained from Invitrogen (see 
table above) and grown at 37°C in DMEM high glucose supplemented with 5% Fetal Bovine 
Serum, 5% Cosmic calf serum and 100 U/mL penicillin/streptomycin (growth media). The parental 
cell line is routinely monitored for mycoplasma contamination but has not been independently 
authenticated after purchasing from Invitrogen. 
 
Methods details: 
Recombinant Protein Expression and Purification 
Human wild-type NDR1KD (amino acids 82–418), NDR1MBD-KD (amino acids 12–418), LATS1KD 
(amino acids 698–1049), MOB1A (amino acids 2–216), RAB3A-interacting protein (RAB3IP, also 
known as Rabin8; amino acids 2–476) and all mutant variants were expressed in E. coli BL21 
(DE3) CodonPlus-RIL cells as Tobacco Etch Virus (TEV) protease-cleavable, dual N-terminal 
6xhistidine (His) and glutathione S-transferase (GST) fusion proteins using a modified pETM-30 
vector. His-GST tagged proteins were purified in batch on glutathione-sepharose resin and eluted by 
cleavage with TEV protease. TEV protease was removed from the eluted protein by subtractive 
immobilized Ni-NTA affinity chromatography. Cleaved proteins were concentrated and further 
purified by size exclusion chromatography (SEC) using a Superdex 75 120 ml column pre-
equilibrated in 25 mM HEPES-NaOH pH 7.5, 100 mM NaCl, and 3 mM DTT. Pooled fractions 
were concentrated to 50 mg/ml, flash-frozen in liquid nitrogen and stored at -80°C. For the 
expression and purification of GST-YAP50–171 (amino acids 50 to 171) and other GST-fusions as 
indicated, the TEV cleavage step was omitted, and proteins were eluted from glutathione-sepharose 
resin with glutathione. 
 
Sedimentation Velocity Analytical Ultracentrifugation 
Concentrations of NDR1, ranging from 5 µM to 40 µM, were tested minimally in duplicate in 
analytical ultracentrifugation buffer (15 mM HEPES-NaOH pH 7.0, 200 mM NaCl, 3 mM DTT). 
Samples were loaded to the two-channel charcoal/Epon60K sedimentation velocity cells, with 
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approximately 350 µl per channel. Centrifugation was conducted with a Beckman ProteomeLab 
XL-I (Bechman Coulter, USA) at a speed of 25,000 RPM and a temperature of 20°C using an An-
60Ti rotor. This produces a depletion of solute near the meniscus and the formation of a sharp 
boundary between the depleted region and the uniform concentration of sedimenting solutes. For 
the ultracentrifugation sedimentation velocity analysis, at least 200 scans of samples were measured 
at a wavelength of 280 nm for each experiment over 7.5 hours, a period of time sufficient for the 
major concentration boundary to migrate to the bottom of the cell. The test mode was based on the 
sedimentation velocity, and a continuous c(s) distribution was applied in the analysis mode. The 
derivative profiles were used to calculate the experimental sedimentation coefficient (S-values). The 
raw dataset of S-values was analyzed by Sedfit (Schuck, 2000), with the model c(s) destruction and 
proper parameters. Data were plotted in Prism (GraphPad). 
 
Crystallization and Data Collection 
Crystals of human NDR1KD bound to AMP-PNP (adenylyl-imidodiphosphate), of the space group 
C2 (a=117.19 Å, b=117.97 Å, c=95.04 Å, alpha=90°, beta=124.88°, gamma=90°) with two 
molecules in the asymmetric unit, were obtained using the hanging drop method by mixing equal 
volumes of 10 mg/ml protein solution (25 mM HEPES-NaOH pH 7.5, 100 mM NaCl, 3 mM DTT, 
and 5 mM MgCl2) with precipitant (4 M ammonium acetate, 0.1 M Bis-Tris propane pH 7.0) in a 
1:1 ratio over a reservoir containing 20 µl of precipitant. NDR1KD crystals formed at 20°C after 48-
72 hours. For X-ray diffraction experiments, crystals were flash-frozen in mother liquor 
supplemented with 20%–25% (v/v) ethylene glycol.  
 
Structure Solution and Refinement 
An X-ray diffraction data set was collected at the Advanced Photon Source (beamline NECAT-24-
ID-C) and processed using the HKL2000 software suite (Otwinowski and Minor, 1997). The human 
NDR1KD structure was solved by molecular replacement with Phaser (McCoy, 2007) using the C-
lobe of RSK-1 kinase domain (amino acids 148-333; PDB ID: 2Z7Q) as a search model. Model 
autobuilding was carried out by Buccaneer (Cowtan, 2006) with manual corrections using Coot 
(Emsley and Cowtan, 2004). Refinement was performed with Refmac (Winn et al., 2003). Structure 
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representations were generated using PyMol (PyMOL Molecualr Graphics System, Version 2). 
Simulated annealing omit maps were generated by Phenix (Afonine et al., 2012). 
 
Radiometric In vitro Kinase Assay  
Protein kinase assays were performed using [gamma-32P]-ATP (Perkin Elmer). For each 10 µl 
reaction, 1 µCi of radiolabeled ATP, 150 µM unlabeled ATP, 2 mM MgCl2, and 2 µM NDR1 or 
LATS1 kinases were used to assess kinase autophosphorylation activity at 30°C for 30 minutes. To 
assess NDR1 or LATS1 substrate phosphorylation, final concentrations of 6 µM RAB3IP or 20 µM 
GST-YAP121-133 were added. The reactions were stopped by the addition of Laemmli (sodium 
dodecylsulfate, SDS) sample loading buffer and incubation at 95°C for 10 minutes. Reactions were 
resolved by SDS polyacrylamide gel electrophoresis (SDS-PAGE) and visualized by 
autoradiography using a Typhoon PhosphorImager (Molecular Dynamics). The resulting 
autoradiograph was analyzed by ImageQuant (GE Healthcare). The calculation of the kinetic 
parameters was performed by fitting the Michaelis-Menten function (y=ax/b+x) to the data 
presented in the Supplemental Figure 18 using GraphPad-Prism 5.0. n=3 experiments done in 
technical duplicate; error bars, SEM. 
 
Limited Proteolysis 
20-µl reactions containing 500 ng/µl of NDR1MBD-KD were incubated with 0.1 ng/µl trypsin (Sigma-
Aldrich) in 25 mM HEPES-NaOH pH 7.0, 200 mM NaCl, and 3 mM DTT at room temperature.  A 
time course of partial proteolysis was carried out, and the reactions were stopped at 0 min, 15 min, 
30 min, 60 min, 120 min, and 240 min by the addition of SDS sample buffer and heated to 95°C for 
10 minutes. When ATP and MgCl2 were used during the trypsin treatment, the kinase : ATP : 
MgCl2 concentration ratio was set at 1:5:50. Reaction samples of the partial proteolysis were 
resolved by SDS-PAGE and stained with Coomassie Blue as seen in Supp. Figure 2A. 
N-terminal boundaries of the indicated protein species were determined by Edman degradation at 
the SPARC BioCentre at The Hospital for Sick Children, Toronto. Briefly, the reaction samples 
were resolved by SDS-PAGE; proteins were subsequently transferred to a polyvinylidene fluoride 
(PVDF) membrane and stained with Coomassie Blue. Desired protein bands were excised from the 
stained membrane and analyzed using an Applied Biosystems Procise 491C Protein Sequencing 
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System (Thermo Fisher Scientific & Perkin Elmer, USA). For detailed mass spectrometry services 
provided by SPARC BioCentre, please visit http://lab.research.sickkids.ca/sparc-molecular-
analysis/services/amino-acid-analysis-and-edman-sequencing/edman-sequencing/. 
 
Intact Mass Determination by Mass Spectrometry  
The integrity and phosphorylation status of wild-type NDR1KD employed for crystallization studies 
was determined using ESI-LC/MS at the AIMS Mass Spectrometry Laboratory in the Department 
of Chemistry at the University of Toronto. 20 µl of 200 µM protein sample in 25 mM HEPES-
NaOH pH 7.5, 100 mM NaCl, and 2 mM DTT was submitted for analysis. Sample was diluted in 
water 1000-fold prior to analysis using an Agilent 6538 Q-TOF interfaced to a 1290 ultrahigh 
pressure HPLC. A list of the ionic formulae was generated by the Molecular Formula Generation 
Algorithm as implemented in the MassHunter data processing software. The Molecular Formulae 
Generation Score takes into account the best match for the mass accuracies and relative abundances 
of the isotopomers identified for the target isotopic envelope. The standard m/z acquisition range for 
biomolecule analysis was set between 200–2000 Da; however, the mass spectrum was expanded to 
highlight the appropriate regions of interest. The reconstructed mass spectrum was generated by the 
Maximum Entropy algorithm in a plot of neutral mass (Da) versus intensity. Selected peaks were 
labeled with mass values rounded to one decimal place. Data processing was performed with the 
MassHunter BioConfirm software package.  
 
Hydrogen-Deuterium Exchange Coupled Mass Spectrometry 
Wild-type NDR1MBD-KD and its 5A activating mutant variant, without or with MOB1A at 1:1 molar 
ratio, were incubated on ice with a tenfold excess of AMP-PNP for 10 minutes prior to starting the 
time course. For each time course, the sample was diluted into 84.5% D2O (v/v), and the final 
concentration of NDR1 protein was 4.5 µM. The buffer conditions were kept constant with 25 mM 
HEPES-NaOH pH 7.5, 200 mM NaCl, 2 mM MgCl2 and 3 mM DTT. A set of standard peptides 
was spiked into the D2O buffer before adding the protein to estimate the methodical back exchange. 
At each desired time point, aliquots of 10 µL were removed from the pool and flash-frozen in liquid 
nitrogen. Quenching was done by adding an equal volume 50 mM ice-cold succinic/citric acid (1:1) 
directly before loading the sample onto the HPLC (Eksigent Tempo, AB SCIEX) system. Pepsin 
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digestion was performed online at room temperature (21°C) on an in-house made fused silica 
column filled with immobilized pepsin (Poros Pepsin, Applied Biosciences). Trap (Poros R1, 
Applied Biosciences) and analytical column (Reprosil C18) were cast in-house as well and 
immersed in water/ice slurry during the analysis.  The sample was loaded directly from the pepsin 
column onto the trap for 4 minutes. The gradient for the analytical column was 15 minutes going 
from 10% buffer A (H2O, 0.1% formic acid) to 60% buffer B (acetonitrile, 0.1% formic acid), 
followed by 10 minutes wash at 80% buffer B. The complete run time was 35 minutes. The analysis 
was followed by two 15-minutes wash gradients to ensure that there was no carry-over between 
samples. An Orbitrap XL was used as the back end and coupled to the HPLC via a nano-
electrospray interface. HDX Workbench (Scripps Institute Florida) was used to analyze the data.  
 
FLAG Affinity Purification Coupled with Mass Spectrometry (AP-MS) for NDR1 Mutants 
Epitope-tagged constructs were generated via Gateway cloning into pDEST 5’BirA*-FLAG 
pcDNA5 FRT TO. Point mutations and deletions were introduced by polymerase chain reaction-
directed mutagenesis (the position of the mutated amino acids is indicated on the basis of the 
reference sequence). All constructs were sequence-verified. Stable cell lines were generated as Flp-
In 293 T-REx cell pools as described (Kean et al., 2012), and expression was induced for 24 hours 
with tetracycline (1 µg/ml; see cell culture conditions above). Okadaic acid (OA; LC Labs, O-5857-
1mg) was added at a concentration of 150 nM for 2.5 hours unless otherwise indicated, and DMSO 
was used as a negative control. In each case, one 15-cm plate was used per biological replicate, and 
two biological replicates were performed. Negative controls consisted of cells expressing BirA*-
FLAG alone that were processed in parallel to the true biological samples. 
 
Cell pellets from one 15-cm plate treated as indicated (150 nM OA, or DMSO as vehicle control for 
2.5 hours) were lysed in 50 mM HEPES-KOH pH 8.0, 100 mM KCl, 2 mM EDTA, 0.1% NP-40, 
and 10% glycerol containing PMSF (1 mM) and Sigma-Aldrich protease inhibitor P8340 (1:500) 
and affinity-purified with M2-FLAG magnetic beads and on-bead digest as described (Kean et al., 
2012). Peptides were analyzed by nano-LCMS using a home-packed 0.75 µm x 10 cm C18 emitter 
tip (Reprosil-Pur 120 C18-AQ, 3 µm). A NanoLC-Ultra HPLC system (Eksigent) was coupled to an 
LTQ Orbitrap Elite or Velos (Thermo Fisher Scientific), and samples were analyzed in data-
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dependent acquisition mode. A 60,000 resolution MS scan was followed by 10 CID MS/MS ion 
trap scans on multiple charged precursor ions with a dynamic exclusion of 20 seconds. The LC 
gradient was delivered at 200 nl/minute and consisted of a ramp of 2-35% acetonitrile (0.1% formic 
acid) over 90 minutes, 35-80% acetonitrile (0.1% formic acid) over 5 milliseconds, 80% acetonitrile 
(0.1% formic acid) for 5 minutes, and then 2% acetonitrile for 20 minutes.  
 
MS Data Analysis for FLAG AP-MS for NDR1 Mutants  
Raw files were converted to mzXML and mgf files using ProteoWizard 3.0.4468 (Kessner et al., 
2008) and analyzed using the iProphet pipeline (Shteynberg et al., 2011) implemented within 
ProHits (Liu et al., 2010) as follows. The database consisted of the human and adenovirus 
sequences in the RefSeq protein database (version 57) supplemented with “common contaminants” 
from the Max Planck Institute (http://141.61.102.106:8080/share.cgi?ssid=0f2gfuB) and the Global 
Proteome Machine (GPM; http://www.thegpm.org/crap/index.html). The search database consisted 
of forward and reverse sequences (labeled “gi|9999” or “DECOY”); in total, 72,226 entries were 
searched. Spectra were analyzed separately using Mascot (2.3.02; Matrix Science) and Comet 
[2012.01 rev.3 (Eng et al., 2013)] for trypsin specificity with up to two missed cleavages; 
deamidation (Asn or Gln) and oxidation (Met) as variable modifications; the mass tolerance of the 
precursor ion was set at +/-12 parts per million (ppm), the fragment ion tolerance at +/- 0.6 amu.  
The resulting Comet and Mascot results were individually processed by PeptideProphet (Keller et 
al., 2002) and combined into a final iProphet output using the Trans-Proteomic Pipeline (TPP; 
Linux version, v0.0 Development trunk rev 0, Build 201303061711). TPP options were as follows: 
general options were -p0.05 -x20 -d“gi|9999,” iProphet options were –ipPRIME, and 
PeptideProphet options were –OpdP. All proteins with a minimal iProphet probability of 0.05 were 
parsed to the relational module of ProHits. For analysis with SAINT, only proteins with an iProphet 
protein probability of >0.95 were considered. Hits were also restricted to those detected with a 
minimum of 2 unique peptides. 
 
Validation of the Interaction with FRYL 
Flp-In T-REx cells expressing BirA*-FLAG-tagged versions of NDR1 wild-type or the Δ38G 
mutant were induced for expression, treated with okadaic acid and harvested and lysed in 1 ml lysis 
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buffer as above. FLAG immunoprecipitation with 12.5 µl packed resin was performed for 2 hours at 
4°C, and resin was washed thrice with lysis buffer prior to elution in boiling 2X Laemmli (SDS) 
sample buffer (50 µl). Immunoprecipitates and total lysates were run on precast Criterion gels (4-
15%; Bio-Rad, 5671084), and proteins were transferred onto nitrocellulose membranes by Western 
blotting. Membranes were blocked in 5% milk in TBS-T; the high-molecular-weight area (> ~120 
kDa) of the membrane was incubated with rabbit anti-FRYL antibody (Bethyl, A302-643A-M; 
1:500) while the lower- molecular-weight area was incubated with mouse anti-FLAG antibody 
(Sigma-Aldrich, F3165; 1:1000). Horseradish-peroxidase-coupled secondary antibodies were from 
GE Healthcare (anti-mouse IgG, NA931-1ML and ECL anti-rabbit IgG, NA934V), and 
chemiluminescence detection was performed using ECL prime Western blotting detection reagent 
(GE Healthcare, 45002401) on film (Clonex BioFlex MSI Film, 2479-MED-CLM5810). 
 
TEAD Luciferase Reporter Assay 
SW480 colorectal adenocarcinoma cells were plated on white 96-well tissue culture plates (30,000 
cells/well) and after one day transfected with 15 ng/well of the 8xGTIIC-luciferase YAP/TAZ-
responsive reporter plasmid (Addgene plasmid # 34615, obtained from Stefano Piccolo; Dupont et 
al., 2011), 2 ng/well of ptkRL (Renilla luciferase control plasmid, Promega) and 80 ng/well of 
pcDNA5 FRT TO-MYC-NDR1 constructs or the corresponding empty vector, filled up to a total of 
100 ng of DNA/well with empty pDNR-MCS SA lacking a promoter (Colwill et al., 2006) as 
carrier DNA. Transfections were done using Lipofectamine 2000 (Thermo Fisher Scientific / 
Invitrogen) with a DNA:transfectant ratio of 1:3 in Opti-MEM II. Media were changed for DMEM 
with 10% FBS 4 hours after the addition of DNA complexes. Twenty hours after media change, 
samples were processed for luminescence readings using the Dual-Luciferase Reporter Assay 
system (Promega) and a Perkin Elmer VICTOR X5 plate reader (5 seconds integration time). Nine 
luciferase reporter experiments were performed in technical duplicate. Individual Firefly and 
Renilla Luciferase activity readings were first background-subtracted. The background-subtracted 
Firefly Luciferase readings were normalised for cell number and transfection efficiency using the 
background-corrected Renilla Luciferase readings. The resulting values from technical duplicates 
were averaged and expressed relative to the vector-only data. A third technical replicate (from 
transfections with the same master mix) was analysed for MYC-NDR1 expression, but more robust 
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detection of overexpressed MYC-NDR1 by Western blotting (see Supplementary Figure 14) 
required larger sample volumes. Transfections for a tenth experiment were therefore set up in 6-well 
plates, using the same transfection master mix as for 96-well plates and scaling up the number of 
cells and quantity of reagents by a factor of 25. Small volumes of the lysate samples were analyzed 
for luciferase activity as before (from a single set of samples) while larger volumes of lysates from 
the same samples were analyzed by SDS-PAGE and Western blotting, using anti-MYC 9E10 
(MA1-81358, Thermo Fisher Scientific, 1:1,000) and anti-b-actin (Abcam, AC-15, ab6276, 
1:10,000) primary antibodies. Western blot signals, from a secondary goat-anti-mouse-DyLight680 
antibody (35518, Thermo Fisher Scientific), were detected using an Odyssey infrared imaging 
system (LI-COR). 
 
Quantification and statistical analysis: 
 
Kinase reactions were resolved by SDS polyacrylamide gel electrophoresis (SDS-PAGE) and 
visualized by autoradiography using a Typhoon PhosphorImager (Molecular Dynamics). The 
resulting autoradiograph was analyzed by ImageQuant (GE Healthcare). The calculation of the 
kinetic parameters was performed by fitting the Michaelis-Menten function (y=ax/b+x) to the data 
presented in the Figure 7 using GraphPad-Prism 5.0. n=3 experiments done in technical duplicate; 
error bars, SEM. 
 
HDX Workbench (Scripps Institute Florida) was used to analyze the Hydrogen-deuterium exchange 
coupled mass spectrometry experiments. For each set of experiments, the percentage of deuterium 
incorporation and the corresponding time points were extracted from the HDX workbench and 
plotted using simple non-linear regression. The results were presented in Figure 6 using GraphPad-
Prism 5.0. n=3 experiments done in technical duplicate; error bars, SEM. 
 
Luciferase reporter data were from nine experiments, each performed in technical duplicate, and a 
scaled-up tenth experiment without technical replicate performed for the parallel, robust detection 
of NDR1 expression levels (see method details). Raw Firefly Luciferase and Renilla Luciferase 
luminescence values were background-subtracted, and normalised reporter activity values 
calculated for each replicate by dividing the background-subtracted Firefly Luciferase by the 
corresponding Renilla Luciferase values for each sample. The normalised values from technical 
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replicates were then averaged and used to calculate the relative reporter activity, as described in the 
method details. Data were expressed as means with SEM.  
 
For the statistical analysis of AP-MS data (see above for the scoring of the mass spectrometry data), 
each bait was analyzed in biological duplicate from cells grown, treated, and processed at different 
times to maximize the variability and increase the robustness in the detection of true interactors. 
Cells expressing the BirA*-FLAG tag alone were used as negative controls and processed in 
parallel to mitigate “batch effect” artifacts (Breitkreutz et al., 2010). The quality of each sample was 
assessed by manually aligning the runs for the biological replicates in ProHits. SAINTexpress 
version 3.6.1 was used with default options (Teo et al., 2014). 14 negative control experiments 
consisting of a) cells expressing FLAG alone treated with DMSO (3) or OA (3) or b) cells 
expressing BirA*-FLAG alone treated with DMSO (4) or OA (4) were compressed to 7 virtual 
controls for SAINTexpress scoring to increase robustness (as in Mellacheruvu et al., 2013). Proteins 
with FDR (False Discovery Rate, Bayesian-estimation) of ≤1% were considered true positive 
interactions. Visualization of the interactions as dot plots was through prohits-viz.lunenfeld.ca 
(Knight et al., 2017) using the default options. Selecting the 1% FDR threshold first identifies all 
interactors that pass the cut-off with at least one bait; in a second step, all quantitative information 
(i.e. averaged spectral counts) for all these interactors across all baits is recovered as a matrix, with 
associated FDRs for each bait-prey pair. This second step prevents bias in which a protein detected 
with several spectral counts would pass the FDR cut-off with one bait, but miss it in the other (with 
would otherwise be shown as an erroneous “0” value). On these dot plots, the color intensity maps 
to the averaged spectral counts across both replicates (capped at a maximal value), while the size of 
the circles is proportional to the maximal spectral count value for the bait across all samples 
analyzed in parallel. The confidence score from SAINTexpress is mapped as the edge color. 
 
 
Data and software availability: 
 
The coordinates of the structures together with the structure factors are deposited at the Protein Data 
Bank. Accession codes and homepages of the software are available in the Key Resources Table. 
The accession numbers for the NDR1 kinase domain structures reported in this paper are PDB code: 
6BXI. 
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AP-MS data: This dataset consisting of 22 raw files and associated peak list and results files has 
been deposited in ProteomeXchange through partner MassIVE as a complete submission and 
assigned the MassIVE ID MSV00008179 and PXD008416, 
ftp://massive.ucsd.edu/MSV000081798. 
 
HDX workbench software is available at Scripps Institute Florida 
(http://hdx.florida.scripps.edu/hdx_workbench/Download_Info.html). 
 
 
 
Supplementary Tables: 
Supplementary Table 1. Complete data set for protein identification of NDR1 interactors in the 
mass spectrometry experiments. (Supp. Table 1 relates to Figure 8B). 
Supplementary Table 2. The complete list of DNA primers used in cloning NDR1 and mutants. 
(Supp. Table 2 relates to Figure 5 and STAR Methods Key Resources Table Oligonucleotides 
section). 
 
Table 1. Crystallographic Data Collection and Refinement Statistics 
 Hs NDR1 + AMP-PNP + Mg2+ 
Space Group C2 
a = 117.2             a = 90° 
b = 118.0             b = 124.9° 
c = 95.0               g = 90° 
Molecules per a. u. (rmsd) 2 (0.051) 
Wavelength (Å) 0.9788 
Resolution (Å) 2.2 
Rsym (high res.) 0.109% (0.491%) 
Total reflections 220717 
Completeness (high res.) 93.7% (87%) 
Redundancy 3.5 
I/s (high res.) 8.333 (1.632) 
Refinement  
Resolution Range (Å) 50-2.2 
Reflections 47691 
Rfactor / Rfree 18% / 20% 
Rms deviations  
Bonds (Å) 0.02 
Angles (°) 2.06 
Average B-factor 
(Activation segment) 
31.2 
(24.6) 
Ramachandran Data  
Most favored 95.6% 
Additionally allowed 4.4% 
Disallowed 0% 
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